Nadia Milad

485 total citations
22 papers, 300 citations indexed

About

Nadia Milad is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Nadia Milad has authored 22 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Nadia Milad's work include Adipose Tissue and Metabolism (7 papers), Muscle Physiology and Disorders (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Nadia Milad is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Muscle Physiology and Disorders (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Nadia Milad collaborates with scholars based in Canada, United States and Australia. Nadia Milad's co-authors include Mathieu C. Morissette, Pascal Bernatchez, Zoe White, Stephanie Sellers, Fábio Rossi, Michael A. Seidman, Mitra Esfandiarei, Lin Tung, Jeremy A. Hirota and James C. Hogg and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Nadia Milad

19 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Milad Canada 11 110 107 100 54 51 22 300
Madelyn S. Hanson United States 11 128 1.2× 39 0.4× 166 1.7× 37 0.7× 24 0.5× 16 363
Mariela Bernabe-Garcı́a Mexico 10 117 1.1× 65 0.6× 83 0.8× 32 0.6× 10 0.2× 28 322
Laura Michalick Germany 10 124 1.1× 82 0.8× 73 0.7× 28 0.5× 9 0.2× 17 304
Lili Tong China 11 114 1.0× 28 0.3× 37 0.4× 30 0.6× 69 1.4× 25 332
Ann‐Marie Gustafson Sweden 9 167 1.5× 67 0.6× 71 0.7× 21 0.4× 9 0.2× 12 391
Nasser A. Elhawary Saudi Arabia 11 139 1.3× 35 0.3× 56 0.6× 20 0.4× 74 1.5× 36 310
Fumiko Tajima Japan 8 85 0.8× 118 1.1× 103 1.0× 63 1.2× 155 3.0× 9 341
Wendy Beattie United Kingdom 8 118 1.1× 42 0.4× 35 0.3× 36 0.7× 36 0.7× 15 319
K.R. Stenmark United States 7 113 1.0× 239 2.2× 118 1.2× 70 1.3× 50 1.0× 17 410
William S. Foster Canada 5 61 0.6× 64 0.6× 123 1.2× 70 1.3× 19 0.4× 6 318

Countries citing papers authored by Nadia Milad

Since Specialization
Citations

This map shows the geographic impact of Nadia Milad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Milad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Milad more than expected).

Fields of papers citing papers by Nadia Milad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Milad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Milad. The network helps show where Nadia Milad may publish in the future.

Co-authorship network of co-authors of Nadia Milad

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Milad. A scholar is included among the top collaborators of Nadia Milad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Milad. Nadia Milad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milad, Nadia, Jenny Nguyen, Quynh Cao, et al.. (2025). Open-source, three-dimensionally printed manifolds for exposure studies using human airway epithelial cells. ERJ Open Research. 11(3). 703–2024.
2.
Milad, Nadia, Peiyao Wang, Sam Afkhami, et al.. (2023). Cannabis smoke suppresses antiviral immune responses to influenza A in mice. ERJ Open Research. 9(6). 219–2023. 4 indexed citations
4.
Milad, Nadia, et al.. (2023). Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective. Journal of Neuromuscular Diseases. 10(6). 1003–1012. 3 indexed citations
5.
Milad, Nadia, et al.. (2022). Smoking status impacts treatment efficacy in smoke-induced lung inflammation: A pre-clinical study. Frontiers in Pharmacology. 13. 971238–971238.
6.
White, Zoe, Lin Tung, Nadia Milad, et al.. (2022). Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects. Scientific Reports. 12(1). 9771–9771. 10 indexed citations
7.
Milad, Nadia, et al.. (2022). Recombinant human β-defensin 2 delivery improves smoking-induced lung neutrophilia and bacterial exacerbation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 323(1). L37–L47. 4 indexed citations
8.
Milad, Nadia, et al.. (2022). Role of progression of training volume on intramuscular adaptations in patients with chronic obstructive pulmonary disease. Frontiers in Physiology. 13. 873465–873465. 1 indexed citations
9.
Milad, Nadia, et al.. (2022). Glycerol contained in vaping liquids affects the liver and aspects of energy homeostasis in a sex‐dependent manner. Physiological Reports. 10(2). e15146–e15146. 8 indexed citations
10.
Milad, Nadia & Mathieu C. Morissette. (2021). Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. European Respiratory Review. 30(162). 210077–210077. 38 indexed citations
11.
White, Zoe, Nadia Milad, Stephanie Sellers, & Pascal Bernatchez. (2021). Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions. Frontiers in Physiology. 12. 675322–675322. 6 indexed citations
12.
White, Zoe, et al.. (2021). Blood pressure‐independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan. Physiological Reports. 9(10). e14877–e14877. 10 indexed citations
13.
White, Zoe, Marine Théret, Nadia Milad, et al.. (2021). Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice. Journal of Cachexia Sarcopenia and Muscle. 13(1). 544–560. 27 indexed citations
14.
Saey, Didier, Nadia Milad, Mathieu C. Morissette, et al.. (2020). Effects of Low-Load/High-Repetition Resistance Training on Exercise Capacity, Health Status, and Limb Muscle Adaptation in Patients With Severe COPD. CHEST Journal. 159(5). 1821–1832. 22 indexed citations
15.
Jubinville, Éric, et al.. (2020). Critical importance of dietary methionine and choline in the maintenance of lung homeostasis during normal and cigarette smoke exposure conditions. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(2). L391–L402. 8 indexed citations
17.
White, Zoe, Nadia Milad, James C. Hogg, et al.. (2019). Sildenafil Prevents Marfan-Associated Emphysema and Early Pulmonary Artery Dilation in Mice. American Journal Of Pathology. 189(8). 1536–1546. 10 indexed citations
18.
Sellers, Stephanie, Nadia Milad, Una Jermilova, et al.. (2018). Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan. American Journal Of Pathology. 188(3). 574–585. 46 indexed citations
19.
Sellers, Stephanie, Nadia Milad, Zoe White, et al.. (2017). Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B. Journal of Lipid Research. 59(2). 261–272. 29 indexed citations
20.
Milad, Nadia, et al.. (2017). Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Skeletal Muscle. 7(1). 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026